Pyrimidin-4-one derivatives and their use as p38 kinase modulators

Details for Australian Patent Application No. 2004226165 (hide)

Owner Pharmacia Corporation

Inventors Hickory, Brian; Devadas, Balekudru; Selness, Shaun; Madsen, Heather; Durley, Richard; Palmquist, Katherine

Agent Shelston IP

Pub. Number AU-B-2004226165

PCT Pub. Number WO2004/087677

Priority 60/460,124 03.04.03 US

Filing date 29 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 8 November 2007

International Classifications

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/52 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087677 Priority application(s): WO2004/087677

12 January 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Dec 2005

8 November 2007 Application Accepted

  Published as AU-B-2004226165

21 February 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 23 Jan 2008. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

20 March 2008 Standard Patent Sealed

3 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 Jan 2008

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226167-Antibodies with enhanced ability to immunomodulate cell functions

2004226164-Benzopyran compounds useful for treating inflammatory conditions